Market Closed -
Nyse
04:00:01 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
34.66
USD
|
+1.46%
|
|
+3.62%
|
-19.86%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
843.6
|
1,615
|
885
|
819.8
|
658.8
|
597.8
|
Enterprise Value (EV)
1 |
1,100
|
1,891
|
1,187
|
1,138
|
993.4
|
952.7
|
P/E ratio
|
34.9
x
|
85
x
|
45.6
x
|
7.51
x
|
31.2
x
|
39
x
|
Yield
|
4.37%
|
2.32%
|
4.29%
|
4.71%
|
5.95%
|
6.66%
|
Capitalization / Revenue
|
10.8
x
|
20.4
x
|
11.1
x
|
9.53
x
|
7.17
x
|
6.18
x
|
EV / Revenue
|
14.1
x
|
23.9
x
|
14.9
x
|
13.2
x
|
10.8
x
|
9.84
x
|
EV / EBITDA
|
20.5
x
|
35.5
x
|
22.4
x
|
19.6
x
|
17
x
|
15.8
x
|
EV / FCF
|
31.3
x
|
49.7
x
|
28.9
x
|
-24.1
x
|
25.7
x
|
24.2
x
|
FCF Yield
|
3.2%
|
2.01%
|
3.46%
|
-4.15%
|
3.89%
|
4.14%
|
Price to Book
|
4.25
x
|
8.88
x
|
5.57
x
|
3.48
x
|
2.88
x
|
2.98
x
|
Nbr of stocks (in thousands)
|
13,746
|
13,757
|
13,771
|
13,784
|
13,802
|
13,823
|
Reference price
2 |
61.37
|
117.4
|
64.27
|
59.47
|
47.73
|
43.25
|
Announcement Date
|
2/27/19
|
2/26/20
|
2/25/21
|
2/24/22
|
2/27/23
|
2/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
77.98
|
78.96
|
79.72
|
85.99
|
91.82
|
96.78
|
EBITDA
1 |
53.64
|
53.22
|
53.1
|
57.96
|
58.27
|
60.15
|
EBIT
1 |
28.88
|
27.55
|
27.71
|
30.66
|
31.86
|
32.56
|
Operating Margin
|
37.03%
|
34.89%
|
34.76%
|
35.66%
|
34.7%
|
33.64%
|
Earnings before Tax (EBT)
1 |
24.2
|
18.96
|
19.45
|
109.2
|
21.1
|
15.4
|
Net income
1 |
24.2
|
18.96
|
19.45
|
109.2
|
21.1
|
15.4
|
Net margin
|
31.03%
|
24.02%
|
24.4%
|
126.96%
|
22.98%
|
15.91%
|
EPS
2 |
1.760
|
1.380
|
1.410
|
7.920
|
1.530
|
1.110
|
Free Cash Flow
1 |
35.16
|
38.06
|
41.05
|
-47.21
|
38.67
|
39.4
|
FCF margin
|
45.09%
|
48.2%
|
51.5%
|
-54.9%
|
42.11%
|
40.71%
|
FCF Conversion (EBITDA)
|
65.56%
|
71.52%
|
77.3%
|
-
|
66.36%
|
65.51%
|
FCF Conversion (Net income)
|
145.33%
|
200.69%
|
211.1%
|
-
|
183.24%
|
255.87%
|
Dividend per Share
2 |
2.680
|
2.720
|
2.760
|
2.800
|
2.840
|
2.880
|
Announcement Date
|
2/27/19
|
2/26/20
|
2/25/21
|
2/24/22
|
2/27/23
|
2/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
256
|
277
|
302
|
318
|
335
|
355
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
4.777
x
|
5.196
x
|
5.688
x
|
5.483
x
|
5.743
x
|
5.901
x
|
Free Cash Flow
1 |
35.2
|
38.1
|
41.1
|
-47.2
|
38.7
|
39.4
|
ROE (net income / shareholders' equity)
|
11.8%
|
9.97%
|
11.4%
|
55.4%
|
9.09%
|
7.16%
|
ROA (Net income/ Total Assets)
|
3.71%
|
3.54%
|
3.52%
|
3.51%
|
3.3%
|
3.38%
|
Assets
1 |
652.8
|
535.6
|
551.8
|
3,112
|
639.1
|
455.6
|
Book Value Per Share
2 |
14.40
|
13.20
|
11.50
|
17.10
|
16.60
|
14.50
|
Cash Flow per Share
2 |
0.3700
|
0.4400
|
0.4200
|
1.630
|
0.5500
|
0.5900
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/19
|
2/26/20
|
2/25/21
|
2/24/22
|
2/27/23
|
2/27/24
|
|
1st Jan change
|
Capi.
|
---|
| -19.86% | 479M | | +4.62% | 55.76B | | -11.72% | 17.72B | | -5.05% | 13.23B | | +1.40% | 7.68B | | -17.93% | 5.39B | | +8.62% | 3.28B | | -5.42% | 3.06B | | -8.15% | 2.73B | | +12.61% | 2.73B |
Healthcare REITs
|